Therefore, to validate the in vitro results, we further tested the antineuroblastoma efficacy of combination of vismodegib and topotecan in NSG mice bearing aggressive MYCN-amplified SK-N-BE(2) neuroblastoma cells. The gene discussed is MYCN; the disease is neuroblastoma.